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Summary 
Glomerular  infiltration by neutrophils is a hallmark of acute glomerulonephritis.  The patho- 
physiological role of interleukin 8 (IL-8), a potent neutrophil chemotactic cytokine (chemokine), 
was explored in an animal model of acute immune complex-mediated glomerulonephritis by 
administering a neutralizing antibody against IL-8. Repeated injection of bovine serum albumin 
(BSA) into rabbits caused the deposition of immune complexes consisting of BSA and rabbit 
IgG in glomeruli. Histological analyses revealed a small but significant number of neutrophils 
in glomeruli and the fusion of epithelial cell foot processes.  Concomitantly, urinary levels of 
protein and albumin increased markedly (3.20 _  0.97 and 1.39  _  0.53 mg/h, respectively) compared 
with those of untreated animals (0.77  •  0.21 and 0.01  +_  0.01 mg/h, respectively). Anti-IL-8 
antibody treatment decreased the number of neutrophils in glomeruli by 40% and dramatically 
prevented the fusion of epithelial cell foot process. Furthermore, treatment with anti-IL-8 antibody 
completely normalized the urinary levels of protein and albumin (0.89  _+ 0.15 and 0.02  •  0.01 
mg/h, respectively). These results indicated that IL-8 participated in the impairment of renal 
functions in experimental acute immune complex-mediated glomerulonephritis through activating 
as well as recruiting neutrophils. 
T 
he acute phase of glomerulonephritis is characterized by 
glomerular infiltration by inflammatory ceils and pro- 
liferation of mesangial cells in the glomerulus (1). Immuno- 
logically mediated processes have been proposed as the basis 
for acute glomerulonephritis (2, 3). Two types of immuno- 
logical mechanisms have been documented to be involved in 
human glomerulonephritis as well as animal models: trapping 
of circulating immune complexes (2) and binding of circulating 
antibody to antigen on the surface of the glomeruli (3). 
In  several  animal  models  of immune complex-induced 
glomerulonephritis,  infiltration  of leukocytes,  particularly 
neutrophils, was observed as the earliest and predominant 
pathological change,  although the precise mechanism and 
pathophysiological role of leukocyte infiltration has not been 
determined (2). We previously observed that the administration 
of a specific neutralizing antibody against a potent polypeptide 
neutrophil  chemotactic  cytokine,  IL-8  (4,  5),  inhibited 
neutrophil-dependent  inflammatory  reactions  as  well  as 
neutrophil infiltration in several experimental animal models, 
including LPS-induced dermatitis (6) and lung reperfusion 
injury (7). Moreover, IL-8 is produced in vitro by mesangial 
and endothelial cells in response to IL-1 or TNF-ot (8). These 
results prompted us to speculate that IL-8 is involved in the 
leukocyte infiltration observed in the acute phase of immune 
complex-induced glomerulonephritis. Thus, we evaluated the 
role of IL-8 in experimental acute immune complex-induced 
glomerulonephritis  in  rabbits  by  administering  a  specific 
neutralizing anti-IL-8 antibody. We observed that anti-IL-8 
antibody treatment prevented albuminuria as welt as infiltration 
of neutrophils  into  glomeruli,  inferring  that  IL-8  is  also 
involved in neutrophil-dependent tissue injury to glomeruli 
initiated by deposition of immune complex. 
Materials  and Methods 
Antibodies and Reagents.  A mouse monoclonal antibody, WS-4 
(IgGIK type), which can neutralize rabbit  Ib8 as well as human 
Ib8, was prepared as previously described (5). This antibody does 
not crossreact with monocyte chemotactic and activating  factor 
(MCAF),  Iblcr  /3,  TNF-c~, Ib6,  and  granulocyte  colony- 
stimulating factor (G-CSF)  (5).  A mouse monoclonal antibody 
against a component of Toxoflasma gondii (IgGl~r type) was used 
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Pure Chemical Industries Ltd. (Osaka, Japan). LPS from Escherichia 
coli 055:B55  was purchased from Difco Laboratories (Detroit, MI). 
CFA was obtained from Iatron (Tokyo, Japan). 
Experimental Design.  On day 0, male Japanese White rabbits 
weighing "~2 kg were injected subcutaneously with 8 mg of ei- 
ther BSA or mouse IgG, dissolved  at 2 mg/ml in physiological sa- 
line, and mixed with an equal volume of CFA. On day 7, animals 
that were given BSA on day 0 received a single intravenous injec- 
tion of 10 #g of LPS in combination with 500 mg of albumin dis- 
solved in 2 ml of physiological saline. On day 8, rabbits were addi- 
tionally  given  10  /xg  of LPS  in  1  ml  of physiological  saline 
intravenously. 4 h after the last administration of LPS, rabbits were 
killed to obtain renal tissue.  Either anti-ILo8 (WS-4) or the control 
antibody (TpM-1) at a dose of 10 mg in 1 ml of physiological saline 
was administered intravenously on both day 7 and 8. Urines were 
collected using a metabolic cage at two  time intervals; from day 
-  1 to the time of injection of either BSA or mouse IgG on day 
0  and  from the injection  time on day 7  to the  time of killing. 
Histopathological Studies.  One portion of the renal tissue was 
fixed in 10% buffered formalin followed by embedding in paraffin 
and staining with hematoxylin and eosin as well as periodic acid- 
Schiff (PAS) reagent. The sections were evaluated by two indepen- 
dent observers without  prior knowledge of the experimental de- 
sign by light microscopy. The total number of PMN stained with 
an alkaline  phosphatase substrate kit II (SK-5200)  and infiltrating 
mononuclear cells were counted on 50 randomly chosen glomeruli. 
Another portion of renal tissue was frozen rapidly and stained with 
either  FITC-conjugated  anti-rabbit  IgG  or  anti-BSA  (Cappel 
Laboratories,  Malvern, PA) as previously described (15). Renal tissue 
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Figure 1.  Effects  of anti-IL-8 
antibody on neutrophil infiltration 
into glomeruli. The numbers of 
z  neutrophils infiltrating glomeruli 
*-  were determined in 50 randomly 
2o  chosen glomeruli from each an- 
imal, examined by two indepen- 
dent  examiners  without  prior 
0  knowledge  about  experimental 
normal  control  antl-lL-8  procedures. 
obtained from normal rabbits was used as a negative control. The 
amount  and  extent  of fluorescence was evaluated  in  at  least  50 
glomeruli and was graded on an arbitrary scale from 0 to 3 (nega- 
tive,  scattered,  weakly diffuse,  and strongly diffuse).  The degree 
of deposition was quantitated  as an immune complex deposition 
index; the mean grade is shown. Several portions of each specimen 
were prefixed with 2.5%  glutaraldehyde and postfixed with 4% 
osmic acid, progressively dehydrated in an alcohol series, embedded 
in Epok 812 (Nagase Industries, Tokyo, Japan), and cut into ultra- 
thin sections.  These were double-stained with uranyl acetate and 
lead  citrate  and  were  examined by electron  microscopy (model 
H-600;  Hitachi,  Tokyo, Japan).  Finally,  the presence of the IL-8 
molecule was immunohistologically examined on the ethanol-fixed 
renal tissue specimens by the indirect avidin-biotinylated peroxi- 
dase  complex  method  using  a  specific  murine  monoclonal 
anti-human Ib8 (clone WS-4) antibody (5) and a peroxidase kit 
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glomeruli showing fusion of the epithelial foot pro- 
cesses. There was no fusion of epithelial foot processes 
of the free wall of glomerular  capillaries in normal 
rabbits (a). Glomeruli from rabbits treated with con- 
trol antibody exhibited a high incidence of fusion of 
epithelial cell foot processes (arrowheads), especially in 
the  vicinity of infiltrating leukocytes  (b,  original 
magnification  x 3,000). In contrast, no fusion of epi- 
thelial foot processes occurred in rabbits treated with 
anti-IL-8 antibody (c, original magnification x3,000), 
even in the presence of infiltrating leukocytes in glo- 
merular capillaries (arrowheads). 
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fine IgG was used as a negative control antibody. 
Urinary and Plasma 11_28  Measurements.  Plasma  was collected at 
killing and urines were kept at  -70~  until the measurement of 
IL-8. Both urinary and plasma IL-8 levels were determined by ELISA, 
as previously reported  (6, 7). All assays were performed  at least 
in duplicate. The detection limit of this ELISA system for IL-8 was 
<50 pg/ml. Urinary IL-8 was standardized by the excreted amount 
of urinary  creatinine. 
Determination of Urinary Protein and Albumin Concentration.  Uri- 
nary protein concentrations were determined by the pyrogarol red 
method (10), whereas urinary albumin was measured by turbidim- 
munometric assay (11) using rabbit serum albumin as standard. Uri- 
nary protein and albumin excretion was expressed  as the total amount 
excreted in  1 h (mg/h). 
Statistical Analysis.  The mean and standard error were calcu- 
lated on all the parameters determined in this study. Statistical anal- 
yses were performed using paired and unpaired Student's t test for 
parametric data and Wilcoxon single-rank sum test for non para- 
metric  data. p <0.05 was accepted as statistically significant. 
Results and Discussion 
Histopathological Studies.  Immunofluorescence analysis re- 
vealed no deposition of BSA and rabbit IgG in glomeruli from 
three untreated rabbits (data not shown). Granular deposits 
of both BSA and rabbit IgG were observed along the glo- 
merular capillaries of 9 rabbits treated with BSA plus the con- 
trol antibody and 10 rabbits treated with BSA plus anti-IL-8 
antibody. Semiquantitative evaluation of deposition revealed 
no significant difference in the deposition of either BSA or 
rabbit IgG between glomeruli from rabbits treated with anti- 
IL-8 and rabbits given control antibody (data not shown), 
indicating that IL-8 had no effect on the process of immune 
complex  deposition.  Infiltration  of 62.7  _+  7.6  PMN/50 
glomeruli was observed in renal tissue from nine rabbits treated 
with BSA plus the control antibody (Fig.  1). The adminis- 
tration  of  anti-IL-8  antibody  decreased  the  number  of 
infiltrating  PMN by >40%  (37.7  +  3.7/50  glomeruli)  al- 
though the number did not return to the level seen in renal 
tissue from normal  rabbits  (Fig.  1).  These results indicate 
that IL-8 was at least partially responsible for the PMN infiltra- 
tion  observed in  immune  complex-induced  glomerulone- 
phritis. Since the anti-IL-8 antibody is highly potent, inhibi- 
tion of the binding of rabbit IL-8 to rabbit neutrophils  by 
50% is obtained at a molar ratio of antibody/IL-8 of 1:1 (6), 
it is very unlikely that the dose of anti-IL-8 monoclonal anti- 
body was insu~cient to neutralize IL-8. Thus,  these results 
suggest  simultaneous  generation  of additional  chemotactic 
factor(s), such as C5a, a potent leukocyte chemotactic factor 
(12),  leukotriene  84  or  other  arachidonic  acid-derived 
lipophilic chemotactic factor(s) (13) or other chemokines, in 
particular,  gro's (14).  The latter possibility is supported by 
the fact that inflammatory stimuli including LPS, IL-1, and 
TNF-oe induce various types of cells to produce gro's (14) 
as well as IL-8. 
The number of mononuclear cells/50 glomeruli of three 
normal rabbits was 13.0  _+  1.8. There was no difference be- 
tween the number of mononuclear cells present/50 glomeruli 
in 9 rabbits given the control antibody (59.7  +  24.5) and 
10 rabbits treated with  anti-IL-8  antibody (45.4  _+  22.6). 
These results do not exclude the possibility that other types 
of leukocytes, such as lymphocytes and monocytes, might 
contribute to glomerular injury over longer periods. This pos- 
sibility will be examined by histological examination of renal 
tissue obtained from a different experimental model of glo- 
merulonephritis  in the chronic  phase. 
Electron microscopical analyses demonstrated few fusion 
of epithelial foot processes in the free wall of the glomerular 
capillaries  from three normal rabbits (Fig.  2 a). In contrast, 
epithelial cell foot processes of all tufts were fused in all tufts, 
especially if there were infiltrating leukocytes nearby, as ex- 
amined in at least  10 glomeruli  from each of 9 rabbits in- 
jected repeatedly with BSA in conjunction with the control 
antibody (Fig.  2 b). In 10 rabbits treated with anti-IL-8 an- 
tibody,  little  fusion  of epithelial  foot  processes occurred, 
even though leukocytes accumulated in glomerular capillaries 
(Fig.  2 c). 
Urinary and Plasma IL-8.  19 normal untreated rabbits ex- 
creted only trace amounts of IL-8 into the urine (2.6  _+  2.6 
pg/d).  However, urinary IL-8 increased significantly at day 
8 in nine rabbits that were repeatedly injected with BSA plus 
the control antibody (80.2  _+  38.4 pg/d),  whereas plasma 
IL-8 was not detected in any rabbits. Next, we examined im- 
munohistochemically the presence of antigenic IL-8 in renal 
tissue. In the glomeruli from three normal rabbits, IL-8 was 
not detected immunohistologically (data not shown). IL-8- 
positive cells,  probably infiltrating  mononuclear  cells  and 
mesangial cells, were observed in almost all glomeruli (at least 
50 glomeruli from each specimen were examined) from nine 
rabbits that  were repeatedly injected with BSA (Fig.  3 a). 
The  staining was specific  for IL-8,  as control  murine  IgG 
did not result in positive staining  (Fig.  3 b).  These results 
favor the notion that IL-8 was locally produced in the glo- 
meruli,  and that IL-8 was causally involved in tissue injury 
in acute immune complex-induced glomerulonephritis by in- 
ducing infiltration of leukocytes, particularly neutrophils. The 
precise identification of the cellular sources of IL-8 remains 
to be done.  Resident cells,  such as mesangial cells  and en- 
dothelial cells as well as infiltrating cells are possible sources 
of IL-8, based on the capacity of these cells to produce IL-8 
in vitro  (4,  8). 
Effects of  Anti-IL-8 Antibody on the Urinary Excretion of  Pro- 
tein and Albumin.  19 normal, untreated rabbits excreted only 
minute amounts  of protein as well as trace amounts of al- 
bumin in the urine (0.77  _+ 0.21, 0.01  _+ 0.01 mg/h, respec- 
tively) (Fig. 4, a and b).  In contrast,  all of the nine rabbits 
treated with BSA plus the control antibody excreted markedly 
elevated amounts of both protein and albumin in the urine 
(3.20  +  0.97,  1.39  _+  0.53 mg/h,  respectively) (Fig.  4, a 
and b). The  administration  of anti-IL-8  antibody dramati- 
cally decreased the excreted amount of protein (0.89  +  0.15 
mg/h)  and albumin (0.02  _+  0.01 mg/h)  (Fig.  4, a and b). 
This indicated that anti-IL-8 antibody normalized the excre- 
tion  of both protein  and albumin,  but not  the neutrophil 
1138  IL8 in Immune Complex-mediated Glomerulonephritis Figure 3.  Immunohistochemical  examination of glomeruli for expression of Ib8 protein in renal tissue. This could be detected using specific mono- 
clonal anti-human IL-8 antibody at  x250 original magnification  (a,  arrows).  A representative result from  10 rabbits treated with control antibody is 
shown. Positive staining was not observed using control murine IgG on the same rabbit  at  x 250 original magnification  (b). 
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1139  Wada et al.  Brief Definitive Report infiltration. Electron microscopical analysis  demonstrated that 
anti-IL-8 antibody treatment prevented the fusion of epithe- 
lial foot processes  even though neutrophils were still infiltrating 
into the glomerular capillaries, inferring that anti-IL-8 anti- 
body treatment blocked impairment of glomerular function 
almost completely. 
The involvement of lysosomal enzymes,  nitrous oxide 
(NO), and reactive oxygen intermediates (ROI) from leuko- 
cytes has been reported to play an essential role in inducing 
tissue injury in glomerulonephritis (15, 16). IL-8 has been 
documented to induce the release of lysosomal enzymes (14) 
and generation of superoxide anions (14) from neutrophils 
in addition to being a chemoattractant for neutrophils. Thus, 
it is tempting to speculate  that IL-8 is causally involved in 
the induction of glomerular injury by recruiting activated 
neutrophils that might be the source of lysosomal enzymes, 
NO or ROI, and that treatment with anti-IL-8 monoclonal 
antibody inhibits the activation as well as the infiltration by 
neutrophils. Collectively, administration of an antagonist to 
IL-8 could provide a key to future treatment of the acute 
phase of human glomerulone ~hritis. 
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